213 related articles for article (PubMed ID: 16234363)
1. The ETS factor TEL2 is a hematopoietic oncoprotein.
Carella C; Potter M; Bonten J; Rehg JE; Neale G; Grosveld GC
Blood; 2006 Feb; 107(3):1124-32. PubMed ID: 16234363
[TBL] [Abstract][Full Text] [Related]
2. TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation.
Kawagoe H; Potter M; Ellis J; Grosveld GC
Cancer Res; 2004 Sep; 64(17):6091-100. PubMed ID: 15342392
[TBL] [Abstract][Full Text] [Related]
3. The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis.
Cardone M; Kandilci A; Carella C; Nilsson JA; Brennan JA; Sirma S; Ozbek U; Boyd K; Cleveland JL; Grosveld GC
Mol Cell Biol; 2005 Mar; 25(6):2395-405. PubMed ID: 15743832
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a new human ETS-family transcription factor, TEL2, that is expressed in hematopoietic tissues and can associate with TEL1/ETV6.
Potter MD; Buijs A; Kreider B; van Rompaey L; Grosveld GC
Blood; 2000 Jun; 95(11):3341-8. PubMed ID: 10828014
[TBL] [Abstract][Full Text] [Related]
5. Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9.
Kawagoe H; Grosveld GC
Blood; 2005 Dec; 106(13):4269-77. PubMed ID: 16105979
[TBL] [Abstract][Full Text] [Related]
6. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow.
Wang LC; Swat W; Fujiwara Y; Davidson L; Visvader J; Kuo F; Alt FW; Gilliland DG; Golub TR; Orkin SH
Genes Dev; 1998 Aug; 12(15):2392-402. PubMed ID: 9694803
[TBL] [Abstract][Full Text] [Related]
7. Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1-positive pediatric leukemia identifies drug-targetable transcription factor activities.
Mehtonen J; Teppo S; Lahnalampi M; Kokko A; Kaukonen R; Oksa L; Bouvy-Liivrand M; Malyukova A; Mäkinen A; Laukkanen S; Mäkinen PI; Rounioja S; Ruusuvuori P; Sangfelt O; Lund R; Lönnberg T; Lohi O; Heinäniemi M
Genome Med; 2020 Nov; 12(1):99. PubMed ID: 33218352
[TBL] [Abstract][Full Text] [Related]
8. ETV6 and ETV7: Siblings in hematopoiesis and its disruption in disease.
Rasighaemi P; Ward AC
Crit Rev Oncol Hematol; 2017 Aug; 116():106-115. PubMed ID: 28693791
[TBL] [Abstract][Full Text] [Related]
9. Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581.
Tomasson MH; Sternberg DW; Williams IR; Carroll M; Cain D; Aster JC; Ilaria RL; Van Etten RA; Gilliland DG
J Clin Invest; 2000 Feb; 105(4):423-32. PubMed ID: 10683371
[TBL] [Abstract][Full Text] [Related]
10. Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosage.
Cain JA; Xiang Z; O'Neal J; Kreisel F; Colson A; Luo H; Hennighausen L; Tomasson MH
Blood; 2007 May; 109(9):3906-14. PubMed ID: 17218386
[TBL] [Abstract][Full Text] [Related]
11. The Tel-PDGFRbeta fusion gene produces a chronic myeloproliferative syndrome in transgenic mice.
Ritchie KA; Aprikyan AA; Bowen-Pope DF; Norby-Slycord CJ; Conyers S; Bartelmez S; Sitnicka EH; Hickstein DD
Leukemia; 1999 Nov; 13(11):1790-803. PubMed ID: 10557054
[TBL] [Abstract][Full Text] [Related]
12. ETV6: a versatile player in leukemogenesis.
Bohlander SK
Semin Cancer Biol; 2005 Jun; 15(3):162-74. PubMed ID: 15826831
[TBL] [Abstract][Full Text] [Related]
13. MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice.
Kawagoe H; Grosveld GC
Blood; 2005 Dec; 106(13):4278-86. PubMed ID: 16081688
[TBL] [Abstract][Full Text] [Related]
14. [Role of TEL gene alterations in childhood leukemias].
Eguchi M
Rinsho Ketsueki; 2011 Aug; 52(8):686-94. PubMed ID: 21897076
[No Abstract] [Full Text] [Related]
15. Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia.
Liu Q; Schwaller J; Kutok J; Cain D; Aster JC; Williams IR; Gilliland DG
EMBO J; 2000 Apr; 19(8):1827-38. PubMed ID: 10775267
[TBL] [Abstract][Full Text] [Related]
16. The leukemia-associated fusion protein Tel-platelet-derived growth factor receptor β (Tel-PdgfRβ) inhibits transcriptional repression of PTPN13 gene by interferon consensus sequence binding protein (Icsbp).
Huang W; Hu L; Bei L; Hjort E; Eklund EA
J Biol Chem; 2012 Mar; 287(11):8110-25. PubMed ID: 22262849
[TBL] [Abstract][Full Text] [Related]
17. ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells.
Fishman H; Madiwale S; Geron I; Bari V; Van Loocke W; Kirschenbaum Y; Ganmore I; Kugler E; Rein-Gil A; Friedlander G; Schiby G; Birger Y; Strehl S; Soulier J; Knoechel B; Ferrando A; Noy-Lotan S; Nagler A; Mulloy JC; Van Vlierberghe P; Izraeli S
Blood; 2022 Jan; 139(3):399-412. PubMed ID: 34624096
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic alteration of bone marrow HSC and microenvironmental association in experimentally induced leukemia.
Basak P; Chatterjee S; Das M; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
Curr Stem Cell Res Ther; 2010 Dec; 5(4):379-86. PubMed ID: 20528754
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of OSTL (RNF217) encoding a RING-IBR-RING protein adjacent to a translocation breakpoint involving ETV6 in childhood ALL.
Fontanari Krause LM; Japp AS; Krause A; Mooster J; Chopra M; Müschen M; Bohlander SK
Sci Rep; 2014 Oct; 4():6565. PubMed ID: 25298122
[TBL] [Abstract][Full Text] [Related]
20. The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity.
Buijs A; van Rompaey L; Molijn AC; Davis JN; Vertegaal AC; Potter MD; Adams C; van Baal S; Zwarthoff EC; Roussel MF; Grosveld GC
Mol Cell Biol; 2000 Dec; 20(24):9281-93. PubMed ID: 11094079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
